Superparamagnetic maghemite nanoparticles from solid-state synthesis – Their functionalization towards peroral MRI contrast agent and magnetic carrier for trypsin immobilization
Source abstract
Abstract
Nearly monodispersed superparamagnetic maghemite nanoparticles (15-20nm) were prepared by a one-step thermal decomposition of iron(II) acetate in air at 400 degrees C. The presented synthetic route is simple, cost effective and allows to prepare the high-quality superparamagnetic particles in a large scale. The as-prepared particles were exploited for the development of magnetic nanocomposites with the possible applicability in medicine and biochemistry. For the purposes of the MRI diagnostics, the maghemite particles were simply dispersed in the bentonite matrix. The resulting nanocomposite represents very effective and cheap oral negative contrast agent for MRI of the gastrointestinal tract and reveals excellent contrast properties, fully comparable with those obtained for commercial contrast material. The results of the clinical research of this maghemite-bentonite contrast agent for imaging of the small bowel are discussed. For biochemical applications, the primary functionalization of the prepared maghemite nanoparticles with chitosan was performed. In this way, a highly efficient magnetic carrier for protein immobilization was obtained as demonstrated by conjugating thermostable raffinose-modified trypsin (RMT) using glutaraldehyde. The covalent conjugation resulted in a further increase in trypsin thermostability (T(50)=61 degrees C) and elimination of its autolysis. Consequently, the immobilization of RMT allowed fast in-solution digestion of proteins and their identification by MALDI-TOF mass spectrometry.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Iron oxide chemistry and applications · Lanthanide and Transition Metal Complexes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (66)
Show source-provided references
1. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging10.1007/s003300100908 ↗
2. In vivo magnetic resonance imaging of transgene expression10.1038/73219 ↗
3. Nanochemistry: synthesis and characterization of multifunctional nanoclinics for biological applications10.1021/cm0203013 ↗
4. Isolation of circulating cancer cell from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro10.1016/S0022-5347(05)63996-1 ↗
5. Optical tracking and detection of immunomagnetically selected and aligned cells10.1038/70761 ↗
6. Magnetic micro- and nano-particle-based targeting for drug and gene delivery10.2217/17435889.1.1.31 ↗
7. Heating patient: a promising approach?10.1093/annonc/mdf280 ↗
8. Applications of magnetic nanoparticles in biomedicine10.1088/0022-3727/36/13/201 ↗
9. Recent advances in iron oxide nanocrystal technology for medical imaging10.1016/j.addr.2006.09.013 ↗
10. Functionalisation of magnetic nanoparticles for applications in biomedicine10.1088/0022-3727/36/13/203 ↗
11. Medical applications of magnetic nanoparticles10.1166/jnn.2006.464 ↗
12. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution10.3109/02652049609026013 ↗
13. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake10.1016/S0142-9612(01)00267-8 ↗
14. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications10.1016/j.biomaterials.2004.10.012 ↗
15. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblast in vitro10.1016/S0142-9612(03)00237-0 ↗
16. Alkyl phosphonate/phosphate coating on magnetite nanoparticles: a comparison with fatty acids10.1021/la010703+ ↗
17. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells10.1038/74464 ↗
18. Implantable applications of chitin and chitosan10.1016/S0142-9612(03)00026-7 ↗
19. Simple synthesis of functionalized superparamagnetic magnetite/silica core/shell nanoparticles and their application as magnetically separable high-performance biocatalysts10.1002/smll.200700456 ↗
20. One-step solid state synthesis of capped gamma-Fe2O3 nanocrystallites10.1088/0957-4484/19/9/095602 ↗
21. Size-controlled synthesis of dextran sulfate coated iron oxide nanoparticles for magnetic resonance imaging10.1088/0957-4484/18/3/035603 ↗
22. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour10.1080/10611860290022651 ↗
23. Composite magnetic particles: 2. Encapsulation of iron oxide by surfactant-free emulsion polymerization10.1016/j.polymer.2005.01.017 ↗
24. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications – a review10.3109/10611869808997890 ↗
25. Transverse relaxivity of particulate MRI contrast media: from theories to experiments10.1002/mrm.1910220203 ↗
26. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil10.1016/0730-725X(95)00024-B ↗
27. Combined small and large bowel MR imaging in patients with Crohn's disease: a feasibility study10.1007/s00330-004-2364-7 ↗
28. Feasibility of evaluating Crohn's disease activity at 3.010.1002/jmri.20650 ↗
29. Comparative efficacy of and sequence choice for two oral contrasts agents used during MR imaging10.2214/ajr.173.1.10397122 ↗
30. MRI of the small and large bowel10.1007/s003300050878 ↗
31. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging10.1148/radiology.175.3.2343116 ↗
32. Oral superparamagnetic contrast agent (ferumoxsil): tolerance and efficacy in MR imaging of gynecologic diseases10.1002/jmri.1880050404 ↗
33. Superparamagnetic iron oxide (SPIO) as an oral contrast agent in gastrointestinal (GI) magnetic resonance imaging (MRI): comparison with state-of-the-art computed tomography (CT)10.1016/0730-725X(95)02044-T ↗
34. Phase III trial of oral magnetic particles in MRI of abdomen and pelvis10.1016/S0009-9260(05)81159-6 ↗
35. Abdominal MRI using a negative contrast agent10.1259/0007-1285-66-785-420 ↗
36. A comparative study between Gd-DTPA and oral magnetic particles (OMP) as gastro-intestinal (GI) contrast agents for MRI of the abdomen10.1016/0730-725X(94)92196-2 ↗
37. Oral superparamagnetic particles for magnetic resonance imaging. Effect in plain and viscous aqueous suspensions10.1177/028418519003100316 ↗
38. Direct binding and characterization of lipase onto magnetic nanoparticles10.1021/bp025587v ↗
39. Activity and stability of alkaline phosphatase (ALP) immobilized onto magnetic nanoparticles (Fe3O4)10.1016/j.jbiotec.2007.06.017 ↗
40. Using high-concentration trypsin-immobilized magnetic nanoparticles for rapid in situ protein digestion at elevated temperature10.1002/rcm.3191 ↗
41. On-chip enzymatic microreactor using trypsin-immobilized superparamagnetic nanoparticles for highly efficient proteolysis10.1016/j.chroma.2007.10.094 ↗
42. Evaluation of the possible proteomic application of trypsin from Streptomyces griseus10.1016/j.ab.2008.01.016 ↗
43. Functionalized magnetic micro- and nanoparticles: optimization and application to μ-chip tryptic digestion10.1002/elps.200500587 ↗
44. Trypsin cleaves exclusively C-terminal to arginine and lysine residues10.1074/mcp.T400003-MCP200 ↗
45. Thermostable trypsin conjugates for high-throughput proteomics: synthesis and performance evaluation10.1002/pmic.200500576 ↗
46. Integration of immobilized trypsin bead beds for protein digestion within a microfluidic chip incorporating capillary electrophoresis separations and an electrospray mass spectrometry interface10.1002/1097-0231(20000815)14:15<1377::AID-RCM31>3.0.CO;2-2 ↗
47. Enzymatic microreactors in chemical analysis and kinetic studies10.1016/j.biotechadv.2005.06.001 ↗
48. Immobilization of trypsin in polyaniline-coated nano-Fe3O4/carbon nanotube composite for protein digestion10.1016/j.aca.2008.02.035 ↗
49. Development of microwave-assisted protein digestion based on trypsin-immobilized magnetic microspheres for highly efficient proteolysis followed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis10.1002/rcm.3283 ↗
50. Immobilization of trypsin on superparamagnetic nanoparticles for rapid and effective proteolysis10.1021/pr070132s ↗
51. Ferrofluids from magnetic-chitosan hybrids10.1021/cm702990t ↗
52. Kinetics of adsorption of Saccharomyces cerevisiae mandelated dehydrogenase on magnetic Fe3O4-chitosan nanoparticles10.1016/j.colsurfa.2008.01.017 ↗
53. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process10.1021/ja016812s ↗
54. Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts10.1039/b409601k ↗
55. One-nanometer-scale size-controlled synthesis of monodisperse magnetic iron oxide nanoparticles10.1002/anie.200461665 ↗
56. Colloidal synthesis and characterization of tetrapod-shaped magnetic nanocrystals10.1021/nl061112c ↗
57. Structural and magnetic properties of uniform magnetite nanoparticles prepared by high temperature decomposition of organic precursors10.1088/0957-4484/17/11/010 ↗
58. Kinetics of monodisperse iron oxide nanocrystal formation by “heating up” process10.1021/ja074633q ↗
59. Iron(III) oxides from thermal processes – synthesis, structural and magnetic properties, Mossbauer spectroscopy characterization and applications10.1021/cm0111074 ↗
60. Magnetic relaxation in fine-particle systems
61. Finite-size effects in fine particles: magnetic and transport properties
62. MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxides agents10.1016/S0730-725X(98)00193-3 ↗
63. Phase I clinical evaluation of a new iron oxide MR contrast agent10.1002/jmri.1880040313 ↗
64. Mashlan M, Bartonkova H, Kluchova K, Medrik I, Zboril R, Oborny J. Patent no: WO 2008/095450 A2.
65. Adsorption of benzene from aqueous-solutions by bentonite treated with quaternary amines10.1002/ep.670090419 ↗
66. Bryant RG, Listinsky JJ. Patent no: 4927624; 1990.